Arcutis Biotherapeutics, Inc. 4

SVP & CFO Latha Vairavan sold 435 shares of Arcutis Biotherapeutics, Inc. common stock at about $21.05 per share to cover taxes after RSU vesting, leaving her with 85,978 shares owned.

On May 11, 2026, Arcutis Biotherapeutics, Inc. SVP and Chief Financial Officer Latha Vairavan sold 435 shares of common stock at approximately $21.05 per share, totaling about $9,160 in value. The Form 4 notes that this sale was effected solely to cover tax withholding obligations arising from the vesting of Restricted Stock Units, indicating a routine, compensation-related transaction rather than a discretionary open-market sale. Following this withholding-related sale, Vairavan beneficially owned 85,978 shares of Arcutis common stock directly.

Filing Facts

CIK

1787306

Ticker

ARQT

Form

4

Source Type

sec

Accession

0002065881-26-000004

Alert Tier

4